Shimony S, Canaani J, Kugler E, Nachmias B, et al. Gilteritinib monotherapy for relapsed/refractory FLT3 mutated acute myeloid leukemia: a real-world, multi-center, matched analysis. Ann Hematol 2022 Jun 24. pii: 10.1007/s00277-022-04895.
PMID: 35739428